RxDoctor Payments Data

Brianne Bagwell, MD

Family Medicine · Salem, OHNPI 1730435975

Payments from drug & device makers

$6,767in general payments, 2019–2025

Across 410 payments — averaging $16.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$607
  • Pfizer$524
  • AstraZeneca$428
  • Novo Nordisk$404
  • GSK$401
  • Astellas Pharma US Inc$374
  • plus $4K from 34 others

What the payments were for

  • Food & beverage$6,767100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,767 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$116,811
Medicare patients
196
Services billed
1,545

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban194$158,303
JardianceEmpagliflozin98$84,569
OzempicSemaglutide66$73,271
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$37,302
JanuviaSitagliptin Phosphate39$33,337
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog21$28,482
TrulicityDulaglutide22$20,714
TradjentaLinagliptin16$15,824
InvokanaCanagliflozin12$13,778
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$13,731
Soliqua 100-33Insulin Glargine/Lixisenatide15$12,635
FarxigaDapagliflozin Propanediol13$12,288
GemtesaVibegron23$11,467
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog19$10,000
LinzessLinaclotide12$9,912

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$524$158,303194 claims
Boehringer IngelheimJardiance, Tradjenta$258$100,393114 claims
Novo NordiskOzempic$404$73,27166 claims
GSKTrelegy Ellipta, Anoro Ellipta, Shingrix$401$55,97979 claims
MerckJanuvia$151$33,33739 claims
Lilly USA, LLCTrulicity$248$20,71422 claims
AstraZenecaFarxiga, Symbicort$428$17,92230 claims
Johnson & JohnsonInvokana$274$13,77812 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$291$12,63515 claims
AbbVieLinzess, Synthroid$607$11,92065 claims
Sumitomo Pharma America, Inc.Gemtesa$203$11,46723 claims
Astellas Pharma US IncMyrbetriq$374$7,40911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Salem

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →